8-K: Aemetis Reports 43% Increase in Annual Revenues for 2024, Reaching $268 Million
Earnings Release
Aemetis announces strong 2024 results with a 43% increase in annual revenues, driven by growth across all business segments.
Summary
- Aemetis reported its financial results for the fourth quarter and year ended December 31, 2024.
- Annual revenues increased by 43% to $268 million, compared to $187 million in 2023.
- India biodiesel annual revenues increased 20% to $93 million.
- India biodiesel annual production capacity increased 33% from 60 mgy to 80 mgy.
- California ethanol annual revenues increased 55% to $162 million.
- Aemetis Biogas increased annual revenues by 139%.
- Aemetis Biogas increased annual production capacity by 80%.
- The company experienced a gross loss of $580 thousand for the year, compared to a gross profit of $2.0 million in the previous year.
- The net loss for the year was $87.5 million, compared to a net loss of $46.4 million in 2023.
- Capital expenditures for carbon intensity reduction and biogas production expansion were $20.3 million.
- Cash at the end of the fourth quarter of 2024 was $898 thousand, compared to $2.7 million at the end of 2023.
- Revenues for the fourth quarter of 2024 were $47.0 million, a decrease from $70.8 million for the fourth quarter of 2023.
- Net loss for the fourth quarter of 2024 was $16.2 million, compared to a net loss of $25.4 million for the fourth quarter of 2023.
Sentiment
Score: 5
Explanation: While revenue growth is positive, increased net losses and decreased cash reserves temper the overall sentiment. The company is making progress in key areas, but financial challenges remain.
Positives
- Aemetis achieved a 43% increase in annual revenues, reaching $268 million.
- The company expanded biodiesel production capacity in India from 60 million gallons per year to 80 million gallons per year.
- Aemetis completed the installation of a 1.9 MW solar microgrid at its California ethanol plant.
- The company received $10.5 million in IRA Section 48C Tax Credits for its ethanol plant.
- Aemetis Biogas increased annual revenues by 139%.
Negatives
- The company reported a gross loss of $580 thousand for the year ended December 31, 2024.
- Aemetis experienced a net loss of $87.5 million for the year ended December 31, 2024.
- Cash reserves decreased to $898 thousand at the end of 2024 from $2.7 million at the end of 2023.
- Revenues for the fourth quarter of 2024 decreased to $47.0 million from $70.8 million in the fourth quarter of 2023.
- Biodiesel sales fell from $22 million during the fourth quarter of 2023 to $3 million due to gap in the OMC tender offers during the fourth quarter of 2024.
Risks
- The company faces risks related to competition in the ethanol, biodiesel, and other industries.
- Aemetis is subject to commodity market risks, including those resulting from weather conditions.
- The company's performance is subject to financial market risks and customer adoption rates.
- Changes to federal policy or regulation could impact Aemetis' operations.
- The company's ability to fund, develop, build, maintain and operate digesters, facilities and pipelines for its Dairy Renewable Natural Gas segment is a risk.
Future Outlook
Aemetis expects to complete low carbon initiatives this year and next. E15 ethanol blends have already been approved by the EPA for eight states with approval for 49 states expected by the end of 2025.
Management Comments
- Revenues for the full year of 2024 were $268 million, an increase of $81 million compared to 2023, driven by significant growth in every business segment, said Todd Waltz, Chief Financial Officer of Aemetis.
- Capital expenditures for carbon intensity reduction and the expansion of biogas production capacity were $20.3 million for 2024 as our engineering and construction teams moved forward with low carbon initiatives that we expect to complete this year and next, added Waltz.
- In addition to achieving important operational milestones during 2024 in all of our business segments, we began generating valuable 45Z tax credits in January 2025, and E15 ethanol blends have already been approved by the EPA for eight states with approval for 49 states expected by the end of 2025, said Eric McAfee, Chairman and CEO of Aemetis.
- Expanding domestic, lower cost energy that provides revenues to farmers and strengthens rural areas is the core of our mission at Aemetis, so we are pleased to see policy support from the White House and Congress for our growth plans, said Eric McAfee, Chairman and CEO of Aemetis.
Industry Context
Aemetis operates in the renewable energy sector, focusing on renewable natural gas and renewable fuels. The company's growth is supported by increasing demand for low-carbon intensity products and government policies promoting renewable energy sources. The company is expanding its production capacity and diversifying its product offerings to capitalize on these trends.
Comparison to Industry Standards
- Aemetis' revenue growth of 43% significantly outpaces the average growth rate in the biofuels industry, which is estimated to be around 5-10% annually.
- Compared to companies like Renewable Energy Group (acquired by Chevron), Aemetis is smaller in scale but demonstrates a focused approach on specific segments like renewable natural gas and sustainable aviation fuel.
- The company's investment in carbon intensity reduction projects aligns with industry trends towards sustainable and environmentally friendly practices, similar to initiatives undertaken by companies like Neste and Darling Ingredients.
- Aemetis' expansion into the Indian biodiesel market positions it to capitalize on the growing demand for biofuels in developing economies, a strategy also pursued by companies like Wilmar International.
Stakeholder Impact
- Shareholders may be concerned about the increased net loss and decreased cash reserves.
- Employees may be affected by the company's financial performance and future strategic decisions.
- Customers will benefit from the company's increased production capacity and expanded product offerings.
- Suppliers may be impacted by the company's financial performance and investment plans.
- Creditors may be concerned about the company's ability to repay its debts.
Next Steps
- Aemetis will host an earnings review call at 11:00 a.m. Pacific time (PT) on March 13, 2025.
- The company plans to continue its investments in low carbon initiatives.
- Aemetis intends to advance toward an initial public offering (IPO) for its India business.
Key Dates
| Date | Description |
|---|---|
| 2006 | Aemetis was founded. |
| December 31, 2023 | End of the 2023 fiscal year, used for comparison in the report. |
| December 31, 2024 | End of the 2024 fiscal year, the primary focus of the report. |
| January 2025 | Aemetis began generating valuable 45Z tax credits. |
| March 13, 2025 | Date of the earnings release and 8-K filing. |
| Q1 2025 | Solar and biogas dairy digester projects finished in 2024 resulted in cash proceeds of $19.4 million from the sale of investment tax credits. |
| End of 2025 | EPA approval for E15 ethanol blends expected for 49 states. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.